EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ceramide Synthase 2 Promotes Cardiac Very-Long-Chain Dihydroceramide Accumulation and Is Linked to Arrhythmias and Heart Failure in Humans

Linda Andersson iD, Mathieu Cinato iD, Elias Björnson, Annika Lundqvist iD, Azra Miljanovic iD, Marcus Henricsson iD, Per-Olof Bergh iD, Martin Adiels, Anders Jeppsson iD, Jan Borén iD, Malin C Levin

International Journal of Molecular Sciences · 17.07.2025 · 26 (14) · 6859

DOI: 10.3390/ijms26146859 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.07.2025. Verfasst von Linda Andersson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Sahlg…. Hauptthemen laut MEDLINE: Ceramides, Arrhythmias, Cardiac, Heart Failure, Sphingosine N-Acyltransferase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Swedish Heart-Lung Foundation, the Swedish state under the agreement between the Swedish government and the country councils, the ALF-agreement,.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myocardial hypoxia/ischemia is associated with abnormal accumulation of myocardial lipids, including dihydroceramides. Here, we characterized how dihydroceramides are remodeled in response to hypoxia and assessed how dihydroceramide remodeling correlates to human cardiac pathophysiology. Hypoxia resulted in a marked accumulation of very-long-chain (VLC)-dihydroceramides in cultured HL-1 cardiomyocytes. In humans, we identified a correlation between the abundance of VLC-dihydroceramides in myocardial biopsies and arrhythmias and heart failure and showed that cardiac expression of CERS2, coding for an enzyme that promotes synthesis of VLC-dihydroceramides, was associated with signaling pathways linked to cardiac arrhythmia and cardiomyopathy. In cultured HL-1 cardiomyocytes, we showed that CerS2 knockdown reduced accumulation of VLC dihydroceramides and altered the expression of mediators regulating Ca2+ cycling and electrical conduction. In conclusion, our findings indicate that increased abundance of VLC-dihydroceramides, promoted by increased activity of CerS2 in response to hypoxia, could play a role in cardiac arrhythmias and heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeramidesArrhythmias, CardiacHeart FailureSphingosine N-AcyltransferaseTumor Suppressor ProteinsHumansMyocytes, CardiacMyocardiumAnimalsMaleMiceFemaleCell LineMembrane Proteins

Stichwörter der Autor:innen

bioactive lipidscardiac sphingolipidsceramide synthasedihydroceramidehypoxia

Substanzen

CeramidesSphingosine N-AcyltransferaseCERS2 protein, humandihydroceramideTumor Suppressor ProteinsMembrane Proteins

Autor:innen und Institutionen

  • Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.
  • Biomarker Discovery and Development, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, 43150 Gothenburg, Sweden.
  • Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.

ORCID-Profile: Linda Andersson, Mathieu Cinato, Annika Lundqvist, Azra Miljanovic, Marcus Henricsson, Per-Olof Bergh, Anders Jeppsson, Jan Borén

Förderung

  • Swedish Research Council
  • Swedish Heart-Lung Foundation
  • the Swedish state under the agreement between the Swedish government and the country councils, the ALF-agreement,
  • the Swedish state under the agreement between the Swedish government and the country councils, the ALF-agreement
  • Swedish Heart and Lung Foundation
  • Swedish state under the agreement between the Swedish government and the country councils, the ALF-agreement

Zitieren

APA

Andersson, L., Cinato, M., Björnson, E., Lundqvist, A., Miljanovic, A., Henricsson, M., Bergh, P. O., Adiels, M., Jeppsson, A., Borén, J., & Levin, M. C. (2025). Ceramide Synthase 2 Promotes Cardiac Very-Long-Chain Dihydroceramide Accumulation and Is Linked to Arrhythmias and Heart Failure in Humans. International Journal of Molecular Sciences, 26(14), 6859. https://doi.org/10.3390/ijms26146859

Vancouver

Andersson L, Cinato M, Björnson E, Lundqvist A, Miljanovic A, Henricsson M, et al. Ceramide Synthase 2 Promotes Cardiac Very-Long-Chain Dihydroceramide Accumulation and Is Linked to Arrhythmias and Heart Failure in Humans. International Journal of Molecular Sciences. 2025;26(14):6859. doi:10.3390/ijms26146859

BibTeX
@article{Andersson2025,
  author = {Andersson, Linda and Cinato, Mathieu and Björnson, Elias and Lundqvist, Annika and Miljanovic, Azra and Henricsson, Marcus and Bergh, Per-Olof and Adiels, Martin and Jeppsson, Anders and Borén, Jan and Levin, Malin C},
  title = {Ceramide Synthase 2 Promotes Cardiac Very-Long-Chain Dihydroceramide Accumulation and Is Linked to Arrhythmias and Heart Failure in Humans},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {14},
  pages = {6859},
  doi = {10.3390/ijms26146859}
}
Kostenlos starten →